澳门第一赌城在线娱乐合作感兴趣的领域
Are you wondering whether your novel science or technology may be of interest to AstraZeneca?
Here is a summary of the key areas in which we are keen to explore collaboration opportunities.
-
Oncology
-
心血管,肾脏和代谢
-
呼吸 & 免疫学
-
疫苗和免疫疗法
-
精密医学
-
支持技术
Oncology
澳门第一赌城在线娱乐有一个大胆的抱负,为各种形式的癌症提供治疗方法. We are following the science to understand cancer and all its complexities to discover, develop and deliver life-changing treatments and increase the potential to save the lives of people around the world.
Thinking differently: how AstraZeneca finds value in the competitive oncology sector through industry-leading dealmaking
心血管,肾脏和代谢
澳门第一赌城在线娱乐大胆的抱负是停止, 通过最大限度地利用澳门第一赌城在线娱乐的药物来逆转和治愈crvrm疾病, 提供创新的解决方案, 推进澳门第一赌城在线娱乐的管道建设.
呼吸 & 免疫学
We are committed to transforming care for some of the most debilitating and chronic respiratory and immune-mediated diseases. 澳门第一赌城在线娱乐的吸入和生物药物组合, 以及澳门第一赌城在线娱乐未来的管道, seek to address the challenges and vast unmet medical needs patients face today.
疫苗和免疫疗法
We are committed to developing and delivering transformative vaccines and antibodies, 为数百万人提供长期免疫, 哪里的疾病负担最重.
精密医学
More than 90 percent of our clinical pipeline now follows a precision medicine approach. We collaborate with a wide range of partners to validate and develop diagnostic devices to regulatory standards globally, and to commercialise innovative biomarker capabilities for patient selection, 疾病鉴定和药物反应. 这些合作涵盖了广泛的尖端技术, 如肿瘤组织诊断, 分子检测, 以及即时诊断.
支持技术
澳门第一赌城在线娱乐对尖端技术感兴趣,以提高质量, effectiveness and productivity of our research and translational capabilities.
在中国,日本和其他国际市场的合作机会
无论你在世界的哪个角落, we are interested in exploring leading-edge collaboration opportunities with you – across our main therapy areas and beyond. We carefully consider local medical circumstances and adopt a flexible approach that enables us to meet specific patient needs in key markets.
In China, 例如, we are exploring opportunities that support and enhance our existing commercial strength. 澳门第一赌城在线娱乐的重点是R的合作机会&D到商业发射阶段, 在儿科等领域, nebulised, pulmonary, gastric, 心血管, 和中医.
In Japan, we are looking to collaborate with a range of experts to help transform medical practice and patients’ lives. We focus on opportunities at or near commercial launch stage in the areas of oncology; 心血管, renal and metabolism; and respiratory and immunology.
Our interest goes beyond pharmaceutical products to 诊断, devices, and 数字技术. We aim to work with a range of partners to build end-to-end patient solutions that help improve disease awareness, diagnosis, 治疗和治疗后护理. While these partnerships are designed to meet the unmet medical needs of local patients, 有些药物也有可能使全球患者受益.
利用澳门第一赌城在线娱乐的存在和影响力, 澳门第一赌城在线娱乐还可以帮助您将产品在中国商业化, 日本等国际市场. 与中国国际金融公司(CICC), 澳门第一赌城在线娱乐成立了澳门在线赌城娱乐-中金医疗投资基金, a private equity fund that promotes the development of medical and healthcare innovation in China by investing in fields such as medicine and biotechnology, 诊断, 医疗设备和数字健康.
Veeva ID: Z4-49876
筹备日期:2022年11月